Current Report Filing (8-k)
January 28 2013 - 5:10PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of
1934
January 27, 2013
Date of Report (date of earliest event reported)
SOLTA MEDICAL,
INC.
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-33123
|
|
68-0373593
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number)
|
25881 Industrial Boulevard, Hayward, California 94545
(Address of principal executive offices)
(510) 782-2286
(Registrants telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
(b) On January 27, 2013, William Brodie advised Solta Medical, Inc. that he
resigned from his position as Vice President of Global Sales. Mr. Brodies role will be assumed by our President, Chief Executive Officer and Chairman, Stephen J. Fanning. Mr. Brodie has agreed to serve as a
consultant for a period of 90 days to assist us in achieving an effective transition of his responsibilities.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
SOLTA MEDICAL, INC.
|
|
|
|
|
Date: January 28, 2013
|
|
|
|
By:
|
|
/s/ John F. Glenn
|
|
|
|
|
|
|
John F. Glenn
|
|
|
|
|
|
|
Chief Financial Officer
|
Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From Jul 2023 to Jul 2024